Headline
The latest stories from AHA Today.
The Food and Drug Administration approved a naloxone hydrochloride nasal spray to treat opioid overdoses that delivers 8 milligrams of naloxone, up from 2 mg or 4 mg in previously approved products.
The Centers for Medicare & Medicaid Services issued a rule finalizing changes to the Comprehensive Care for Joint Replacement model, which bundles payment to acute care hospitals for hip and knee replacement surgery.
The Centers for Medicare & Medicaid Services released a second final notice of benefit and payment parameters to implement standards governing health insurance issuers and marketplaces for 2022 that were not finalized in the Jan. 19 final rule.
The National Institutes of Health awarded $29 million from the American Rescue Plan Act to support and expand its Community Engagement Alliance (CEAL) Against COVID-19 Disparities, which conducts community-engaged research and outreach to strengthen COVID-19 vaccine confidence and access, testing…
The Centers for Medicare & Medicaid Services Office of Minority Health will host a May 13 webinar on building COVID-19 vaccine confidence.
Detroit-based Henry Ford Health System developed and implemented a framework connecting clinicians with laboratory professionals, which improved collaboration, removed process waste, improved patient outcomes and resulted in process efficiencies.
WakeMed Health & Hospitals in 2017 faced a behavioral health crisis in the system’s seven emergency departments, with patients waiting days to get access to acute inpatient services.
The Senate Health, Education, Labor & Pensions Committee held a hearing on using COVID-19 response lessons to address the mental health and substance use disorder crises.
Providence, Henry Ford Health System and Northwell Health joined with other health care providers to form Truveta, a platform that de-identifies data and uses artificial intelligence to mine datasets, providing new insights into the unique needs of their patient populations.
The Food and Drug Administration updated its webpage on the performance of SARS-CoV-2 serology tests authorized for emergency use to help health care providers interpret these antibody test results for their patients.